NEW YORK, Dec. 4, 2012 /PRNewswire/ --
Young Innovations, Inc.Levi & Korsinsky is investigating the Board of Directors of Young Innovations, Inc. (NasdaqGS: YDNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to an affiliate of Linden Capital Partners for $39.50 per share. Young Innovations stock traded above the offer price as recently as September 27, 2012.
Click here to learn more about the investigation: http://zlk.9nl.com/young-innovations-ydnt/ , or call: 877-363-5972.
Peregrine Pharmaceuticals, Inc.Levi & Korsinsky is investigating potential claims on behalf of purchasers of Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities concerning possible breaches of fiduciary duty in connection with the disclosure of the discovery of major discrepancies in the treatment group of its Bavituxmab Phase II Second-Line Non-Small Cell Lung Cancer Trial.For more information, click here : http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/ . Health Management Associates, Inc.Levi & Korsinsky is investigating potential claims on behalf of purchasers of Health Management Associates, Inc. (NYSE: HMA) securities concerning possible breaches of fiduciary duty. For more information, click here : http://zlk.9nl.com/health-management-hma/. On August 3, 2011, the Company announced that the U.S. Department of Health and Human Services (DHHS) had issued a subpoena requesting information concerning Health Management's physician referrals. As a result, shares in the Company's common stock dropped by $0.80, closing at $7.97 per share. Five months later, on January 9, 2012, an analyst from CRT Capital Group reported a lawsuit had been filed against the Company under Florida's Private Sector Whistleblower's Act by its former compliance director, Paul Meyer. Meyer alleges he was unlawfully terminated after reporting what he believed to be Medicare fraud, which also included fraudulent billing. Health Management's common stock fell yet again $0.53, dropping from $7.49 to $6.96 per share. Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT: Levi & Korsinsky, LLP Joseph Levi, Esq.30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (866) 367-6510 www.zlk.com (Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO) SOURCE Levi & Korsinsky, LLP
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV